Royal Bank of Canada’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-15,000
Closed -$9K 7419
2024
Q3
$9K Sell
15,000
-2,726
-15% -$1.53K ﹤0.01% 6378
2024
Q2
$11K Buy
17,726
+685
+4% +$579 ﹤0.01% 6315
2024
Q1
$44K Sell
17,041
-27,357
-62% -$66.8K ﹤0.01% 5596
2023
Q4
$91K Buy
44,398
+8,799
+25% +$16.1K ﹤0.01% 5677
2023
Q3
$61K Buy
35,599
+11,123
+45% +$19.7K ﹤0.01% 5680
2023
Q2
$48K Buy
24,476
+6,849
+39% +$16K ﹤0.01% 5804
2023
Q1
$49K Buy
17,627
+2,608
+17% +$7.45K ﹤0.01% 5640
2022
Q4
$52K Sell
15,019
-6,270
-29% -$17.9K ﹤0.01% 5861
2022
Q3
$56K Buy
21,289
+6,089
+40% +$19.4K ﹤0.01% 5680
2022
Q2
$36K Sell
15,200
-3,026
-17% -$7.95K ﹤0.01% 5864
2022
Q1
$75K Sell
18,226
-3,620
-17% -$19.2K ﹤0.01% 5834
2021
Q4
$281K Buy
21,846
+1
+0% +$11 ﹤0.01% 5003
2021
Q3
$236K Buy
21,845
+2,071
+10% +$18.8K ﹤0.01% 5025
2021
Q2
$180K Buy
19,774
+15,191
+331% +$140K ﹤0.01% 5166
2021
Q1
$43K Buy
4,583
+2,293
+100% +$31.6K ﹤0.01% 5992
2020
Q4
$9K Buy
2,290
+2,274
+14,213% +$6.88K ﹤0.01% 6449
2020
Q3
$0 Sell
16
-111
-87% -$412 ﹤0.01% 7011
2020
Q2
$1K Sell
127
-773
-86% -$5.21K ﹤0.01% 6506
2020
Q1
$5K Sell
900
-1,850
-67% -$15.5K ﹤0.01% 6060
2019
Q4
$24K Sell
2,750
-40,675
-94% -$339K ﹤0.01% 5787
2019
Q3
$375K Sell
43,425
-44
-0.1% -$445 ﹤0.01% 4031
2019
Q2
$484K Buy
43,469
+25,369
+140% +$290K ﹤0.01% 3887
2019
Q1
$241K Buy
18,100
+8,525
+89% +$114K ﹤0.01% 4237
2018
Q4
$148K Buy
+9,575
New +$183K ﹤0.01% 4522

Other funds holding GRTS

Royal Bank of Canada's GRTS Position: Q4 2024 in Review

Royal Bank of Canada sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q4 2024, closing a stake of 15,000 shares — an estimated $9K sold.

Royal Bank of Canada first reported a position in GRTS in Q4 2018 and held it in 24 quarters. The position peaked at $484K in Q2 2019. 6 funds tracked by Wall St. Rank hold GRTS as of Q4 2024.

  • Royal Bank of Canada reported no remaining Gritstone bio, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Royal Bank of Canada sold 15,000 Gritstone bio, Inc. Common Stock shares in Q4 2024, an estimated $9K.
  • Royal Bank of Canada first reported a position in Gritstone bio, Inc. Common Stock in Q4 2018 and held it in 24 quarters.
  • Royal Bank of Canada's Gritstone bio, Inc. Common Stock position peaked at $484K in Q2 2019.
  • 6 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q4 2024.

Based on Royal Bank of Canada's 13F filing for Q4 2024, filed 14 Feb 2025.